Efficacy of Pregabalin for Patients With Irritable Bowel Syndrome | MicrobiomeTrials← Back to trialsNCT07635394
Efficacy of Pregabalin for Patients With Irritable Bowel Syndrome
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-04-07Est. Completion: 2026-04-08
Enrollment target: 258 participants Locations- Beijing Tiantan Hospital, Beijing, Beijing Municipality, China
Other microbiome trials you might be interested in
Irritable Bowel Syndrome
Irritable Bowel Syndrome (IBS), characterized by the Rome IV criteria, is a functional bowel disorder combining abdomina…
Lyon, FranceEst. completion Oct 10, 2028
Intestinal Disease
The gut microbiota plays a crucial role in human health, influencing metabolism, immunity, and pathogen resistance. Rese…
Rome, ItalyEst. completion Mar 10, 2027
Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder that substantially affects quality of li…
Istanbul, Turkey (Türkiye)Completed Nov 25, 2021